C5aR2 (C5L2/gp77) is a seven-transmembrane spanning receptor that binds to C5a but lacks motifs essential for G protein coupling and associated signal transduction. C5aR2 is expressed on immune cells, modulates various inflammatory diseases in mice, and has been shown to facilitate murine and human regulatory T cell (T) generation in vitro. Whether and how C5aR2 impacts in vivo T generation and pathogenic T cell-dependent disease models have not been established. In this article, we show that murine T cells express and upregulate C5aR2 during induced T (iT) generation and that the absence of T cell-expressed C5aR2 limits in vivo iT generation following adoptive transfer of naive CD4 T cells into recipients. Using newly generated C5aR2-transgenic mice, we show that overexpression of C5aR2 in naive CD4 T cells augments in vivo iT generation. In a model of T-dependent cardiac allograft survival, recipient C5aR2 deficiency accelerates graft rejection associated with lower T/effector T cell ratios, whereas overexpression of C5aR2 in immune cells prolongs graft survival associated with an increase in T/effector T cell ratios. T cell-expressed C5aR2 modulates T induction without altering effector T cell proliferation or cytokine production. Distinct from reported findings in neutrophils and macrophages, T-expressed C5aR2 does not interact with β-arrestin or inhibit ERK1/2 signaling. Rather, cumulative evidence supports the conclusion that C5aR2 limits C5aR1-initiated signals known to inhibit T induction. Together, the data expand the role of C5aR2 in adaptive immunity by providing in vivo evidence that T cell-expressed C5aR2 physiologically modulates iT generation and iT-dependent allograft survival.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894525 | PMC |
http://dx.doi.org/10.4049/jimmunol.1701638 | DOI Listing |
J Coll Physicians Surg Pak
December 2024
Department of Pathology, Army Medical College/Pak. Emirates Military Hospital (PEMH), Rawalpindi, Pakistan.
Objective: To determine the relation between C5aR2 and clinicopathological parameters of breast cancer. Study Design: Observational study. Place and Duration of the Study: Department of Histopathology, PNS Shifa Hospital, Karachi, from January to June 2023.
View Article and Find Full Text PDFComput Biol Chem
February 2025
Chemical Biology Laboratory, School of Basic Sciences, Indian Institute of Technology Bhubaneswar, Odisha 752050, India. Electronic address:
Methotrexate (MTX) is an antimetabolite drug that mimics folate and inhibits dihydrofolic acid reductase, resulting in the impairment of malignant growth in actively proliferating tissues. MTX is approved by the FDA for primarily treating non-Hodgkin lymphoma, lymphoblastic leukemia, and osteosarcoma. In addition, MTX is also prescribed as a preferred anti-rheumatic medication for the management of rheumatoid arthritis, including psoriasis, indicating that MTX has a multipronged mechanism of action.
View Article and Find Full Text PDFPLoS Genet
August 2024
Interdisciplinary Program in Genetics and Genomics, Texas A&M University, College Station, Texas, United States of America.
Staphylococcus aureus (S. aureus) colonizes humans asymptomatically but can also cause opportunistic infections, ranging from mild skin infections to severe life-threatening conditions. Resistance and tolerance are two ways a host can survive an infection.
View Article and Find Full Text PDFJ Med Chem
August 2024
Chemical Biology Laboratory, School of Basic Sciences, Indian Institute of Technology Bhubaneswar, Bhubaneswar, Odisha 752050, India.
C5a is an integral glycoprotein of the complement system that plays an important role in inflammation and immunity. The physiological concentration of C5a is observed to be elevated under various immunoinflammatory pathophysiological conditions in humans. The pathophysiology of C5a is linked to the "two-site" protein-protein interactions (PPIs) with two genomically related receptors, such as C5aR1 and C5aR2.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!